Pinnacle Wealth Planning Services’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
SCM
QCM
Pinnacle Wealth Planning Services's NVCR Position: Q2 2026 in Review
Pinnacle Wealth Planning Services reduced its NovoCure (NVCR) stake by 53% in Q2 2026, selling an estimated $1.07K and leaving 62 shares worth $939. The position accounts for ﹤0.01% of the portfolio, ranked #2590.
Pinnacle Wealth Planning Services first reported a position in NVCR in Q4 2020 and has held it in 4 quarters since. The position peaked at $30K in Q4 2020. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.
- Pinnacle Wealth Planning Services held 62 shares of NovoCure worth $939 as of Q2 2026.
- Pinnacle Wealth Planning Services sold 71 NovoCure shares in Q2 2026, an estimated $1.07K.
- NovoCure made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #2590 holding.
- Pinnacle Wealth Planning Services first reported a position in NovoCure in Q4 2020 and has held it in 4 quarters since.
- Pinnacle Wealth Planning Services's NovoCure position peaked at $30K in Q4 2020.
- 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.